% alzhub.org library filter
% Source: https://alzhub.org/research?journal=Nature+reviews.+Drug+discovery
% 18 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{corbett2012-23123941,
  author  = {Corbett, A. and Pickett, J. and Burns, A. and Corcoran, J. and Dunnett, S. B. and Edison, P. and Hagan, J. J. and Holmes, C. and others},
  title   = {{Drug repositioning for Alzheimer's disease}},
  journal = {Nature reviews. Drug discovery},
  year    = {2012},
  doi     = {10.1038/nrd3869},
  pmid    = {23123941},
  url     = {https://doi.org/10.1038/nrd3869}
}

@article{karran2022-35177833,
  author  = {Karran, E. and De Strooper, B.},
  title   = {{The amyloid hypothesis in Alzheimer disease: new insights from new therapeutics}},
  journal = {Nature reviews. Drug discovery},
  year    = {2022},
  doi     = {10.1038/s41573-022-00391-w},
  pmid    = {35177833},
  url     = {https://doi.org/10.1038/s41573-022-00391-w}
}

@article{lee2022-35173313,
  author  = {Lee, H. G. and Wheeler, M. A. and Quintana, F. J.},
  title   = {{Function and therapeutic value of astrocytes in neurological diseases}},
  journal = {Nature reviews. Drug discovery},
  year    = {2022},
  doi     = {10.1038/s41573-022-00390-x},
  pmid    = {35173313},
  url     = {https://doi.org/10.1038/s41573-022-00390-x}
}

@article{boland2018-30116051,
  author  = {Boland, B. and Yu, W. H. and Corti, O. and Mollereau, B. and Henriques, A. and Bezard, E. and Pastores, G. M. and Rubinsztein, D. C. and others},
  title   = {{Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing}},
  journal = {Nature reviews. Drug discovery},
  year    = {2018},
  doi     = {10.1038/nrd.2018.109},
  pmid    = {30116051},
  url     = {https://doi.org/10.1038/nrd.2018.109}
}

@article{forman2021-34194012,
  author  = {Forman, H. J. and Zhang, H.},
  title   = {{Targeting oxidative stress in disease: promise and limitations of antioxidant therapy}},
  journal = {Nature reviews. Drug discovery},
  year    = {2021},
  doi     = {10.1038/s41573-021-00233-1},
  pmid    = {34194012},
  url     = {https://doi.org/10.1038/s41573-021-00233-1}
}

@article{scearcelevie2020-32612262,
  author  = {Scearce-Levie, K. and Sanchez, P. E. and Lewcock, J. W.},
  title   = {{Leveraging preclinical models for the development of Alzheimer disease therapeutics}},
  journal = {Nature reviews. Drug discovery},
  year    = {2020},
  doi     = {10.1038/s41573-020-0065-9},
  pmid    = {32612262},
  url     = {https://doi.org/10.1038/s41573-020-0065-9}
}

@article{lohela2022-35948785,
  author  = {Lohela, T. J. and Lilius, T. O. and Nedergaard, M.},
  title   = {{The glymphatic system: implications for drugs for central nervous system diseases}},
  journal = {Nature reviews. Drug discovery},
  year    = {2022},
  doi     = {10.1038/s41573-022-00500-9},
  pmid    = {35948785},
  url     = {https://doi.org/10.1038/s41573-022-00500-9}
}

@article{li2017-28983098,
  author  = {Li, C. and Götz, J.},
  title   = {{Tau-based therapies in neurodegeneration: opportunities and challenges}},
  journal = {Nature reviews. Drug discovery},
  year    = {2017},
  doi     = {10.1038/nrd.2017.155},
  pmid    = {28983098},
  url     = {https://doi.org/10.1038/nrd.2017.155}
}

@article{hauser2017-29075003,
  author  = {Hauser, A. S. and Attwood, M. M. and Rask-Andersen, M. and Schiöth, H. B. and Gloriam, D. E.},
  title   = {{Trends in GPCR drug discovery: new agents, targets and indications}},
  journal = {Nature reviews. Drug discovery},
  year    = {2017},
  doi     = {10.1038/nrd.2017.178},
  pmid    = {29075003},
  url     = {https://doi.org/10.1038/nrd.2017.178}
}

@article{cunnane2020-32709961,
  author  = {Cunnane, S. C. and Trushina, E. and Morland, C. and Prigione, A. and Casadesus, G. and Andrews, Z. B. and Beal, M. F. and Bergersen, L. H. and others},
  title   = {{Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing}},
  journal = {Nature reviews. Drug discovery},
  year    = {2020},
  doi     = {10.1038/s41573-020-0072-x},
  pmid    = {32709961},
  url     = {https://doi.org/10.1038/s41573-020-0072-x}
}

@article{andersson2014-24781550,
  author  = {Andersson, E. R. and Lendahl, U.},
  title   = {{Therapeutic modulation of Notch signalling--are we there yet?}},
  journal = {Nature reviews. Drug discovery},
  year    = {2014},
  doi     = {10.1038/nrd4252},
  pmid    = {24781550},
  url     = {https://doi.org/10.1038/nrd4252}
}

@article{citron2010-20431570,
  author  = {Citron, M.},
  title   = {{Alzheimer's disease: strategies for disease modification}},
  journal = {Nature reviews. Drug discovery},
  year    = {2010},
  doi     = {10.1038/nrd2896},
  pmid    = {20431570},
  url     = {https://doi.org/10.1038/nrd2896}
}

@article{lipton2006-16424917,
  author  = {Lipton, S. A.},
  title   = {{Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond}},
  journal = {Nature reviews. Drug discovery},
  year    = {2006},
  doi     = {10.1038/nrd1958},
  pmid    = {16424917},
  url     = {https://doi.org/10.1038/nrd1958}
}

@article{karran2011-21852788,
  author  = {Karran, E. and Mercken, M. and De Strooper, B.},
  title   = {{The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics}},
  journal = {Nature reviews. Drug discovery},
  year    = {2011},
  doi     = {10.1038/nrd3505},
  pmid    = {21852788},
  url     = {https://doi.org/10.1038/nrd3505}
}

@article{brunden2009-19794442,
  author  = {Brunden, K. R. and Trojanowski, J. Q. and Lee, V. M.},
  title   = {{Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies}},
  journal = {Nature reviews. Drug discovery},
  year    = {2009},
  doi     = {10.1038/nrd2959},
  pmid    = {19794442},
  url     = {https://doi.org/10.1038/nrd2959}
}

@article{supuran2008-18167490,
  author  = {Supuran, C. T.},
  title   = {{Carbonic anhydrases: novel therapeutic applications for inhibitors and activators}},
  journal = {Nature reviews. Drug discovery},
  year    = {2008},
  doi     = {10.1038/nrd2467},
  pmid    = {18167490},
  url     = {https://doi.org/10.1038/nrd2467}
}

@article{taly2009-19721446,
  author  = {Taly, A. and Corringer, P. J. and Guedin, D. and Lestage, P. and Changeux, J. P.},
  title   = {{Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system}},
  journal = {Nature reviews. Drug discovery},
  year    = {2009},
  doi     = {10.1038/nrd2927},
  pmid    = {19721446},
  url     = {https://doi.org/10.1038/nrd2927}
}

@article{pangalos2007-17599084,
  author  = {Pangalos, M. N. and Schechter, L. E. and Hurko, O.},
  title   = {{Drug development for CNS disorders: strategies for balancing risk and reducing attrition}},
  journal = {Nature reviews. Drug discovery},
  year    = {2007},
  doi     = {10.1038/nrd2094},
  pmid    = {17599084},
  url     = {https://doi.org/10.1038/nrd2094}
}